Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioCardia Inc (BCDA)
NASDAQ:BCDA
BioCardia (BCDA) Stock Price & Analysis
186 Followers
BCDA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.36 - $2.92
Previous Close$0.37
Volume21.02K
Average Volume (3M)383.82K
Market Cap
$10.11M
Enterprise Value$9.45M
Total Cash (Recent Filing)$1.83M
Total Debt (Recent Filing)$1.40M
Price to Earnings (P/E)-0.7
Beta0.51
Next Earnings
May 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.55
Shares Outstanding26,732,542
10 Day Avg. Volume90,904
30 Day Avg. Volume383,819
Standard Deviation0.26
R-Squared0.10
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-14.75
Price to Sales (P/S)92.83
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue16.58
Enterprise Value/Gross Profit6.99
Enterprise Value/Ebitda-1.90
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioCardia News
PremiumPre-Earnings
Is BCDA a Buy, Before Earnings?
PremiumCompany Announcements
BioCardia Partners with StemCardia for Heart Therapy Trials
Ownership Overview
21.87% Insiders
2.98% Mutual Funds
2.62% Other Institutional Investors
72.54% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BCDA FAQ
What was BioCardia Inc’s price range in the past 12 months?
BioCardia Inc lowest stock price was $0.36 and its highest was $2.92 in the past 12 months.
What is BioCardia Inc’s market cap?
Currently, no data Available
When is BioCardia Inc’s upcoming earnings report date?
BioCardia Inc’s upcoming earnings report date is May 08, 2024 which is in 19 days.
How were BioCardia Inc’s earnings last quarter?
BioCardia Inc released its earnings results on Mar 27, 2024. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.075 by -$0.015.
Is BioCardia Inc overvalued?
According to Wall Street analysts BioCardia Inc’s price is currently Overvalued.
Does BioCardia Inc pay dividends?
BioCardia Inc does not currently pay dividends.
What is BioCardia Inc’s EPS estimate?
BioCardia Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioCardia Inc have?
BioCardia Inc has 26,867,520 shares outstanding.
What happened to BioCardia Inc’s price movement after its last earnings report?
BioCardia Inc reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.075. Following the earnings report the stock price went down -2.381%.
Which hedge fund is a major shareholder of BioCardia Inc?
Currently, no hedge funds are holding shares in BCDA
---
BioCardia Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
BCDA Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $5.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.13%
12-Months-Change
Fundamentals
Return on Equity
-703.62%
Trailing 12-Months
Asset Growth
-69.50%
Trailing 12-Months
Company Description
BioCardia Inc
BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.
---
BCDA Earnings Call
Q4 2024
0:00 / 0:00
---
BCDA Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering BCDA
1 Year
1 Year Success Rate
0/10 ratings generated profit
1 Year Average Return
-60.04%
reiterated a buy rating 5 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -60.04% per trade.
---